Sector: Pharmaceuticals & Biotechnology
|Large Cap
Divi's Laboratories Share Price
Divi's Laboratories Ltd.
₹6,743
Invest in DIVISLAB with up to 2.86x margin.
Trade with MTFDivi's Laboratories Performance
Price Movement
₹6661.00
₹6805.00
1 Year Performance
₹5636.50
₹7071.50
Markets Today
Historical Performance
Divi's Laboratories Fundamentals
Divi's Laboratories Financials
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 2,793 | 2,578 | 2,660 | 2,357 | 2,536 |
| Operating Expense | 1,850 | 1,671 | 1,765 | 1,614 | 1,655 |
| Operating Profit | 943 | 907 | 895 | 743 | 881 |
| Depreciation | 120 | 116 | 113 | 112 | 107 |
| Interest | 6 | 6 | 8 | 3 | 0 |
| Tax | 215 | 200 | 224 | 190 | 194 |
| Net Profit | 756 | 598 | 696 | 557 | 667 |
DIVISLAB Stock Recommendation by HDFC
Research Type
Equity , Long Term
Buy Range
₹6,363 - ₹0
Target Price
₹7,630
Stop Loss
-
Target Date
7 Jan 27
Potential Returns
19.91 %
Divi's Laboratories Technicals
Divi's Laboratories Ltd. EMA & SMA
₹6743.00
↗ Bullish Moving Average
11
↘ Bearish Moving Average
5
Divi's Laboratories Support and Resistance
Resistance
Support
Technical Indicators
Divi's Laboratories Shareholding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 51.9 | 51.9 | 51.9 | 51.9 | 51.9 | 51.9 |
| FII | 18 | 18 | 19.7 | 19.4 | 20.1 | 20.3 |
| DII | 20.5 | 20.7 | 19.1 | 19.8 | 19.3 | 19.2 |
| Public | 9.6 | 9.4 | 9.3 | 9 | 8.8 | 8.6 |
Divi's Laboratories Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 4.68 L | 9.96 L | 46.97% |
| Week | 3.31 L | 5.77 L | 57.37% |
| 1 Month | 2.19 L | 3.84 L | 57.05% |
| 6 Month | 2 L | 3.5 L | 57.09% |
Divi's Laboratories SWOT Analysis
Companies with no Debt
Benjamin Graham Value Screen
Strong Momentum: Price above short, medium and long term moving averages
Consistent high performing stocks over Five Years
Expensive Performers (DVM)
Annual Profit Growth higher than Sector Profit Growth
High Momentum Scores (Technical Scores greater than 50)
Results in the last two days with YoY and QoQ Net Profit Growth
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Near 52 Week High
Negative to Positive growth in Sales and Profit with Strong Price momentum
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Divi's Laboratories Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 25 Jul, 2025 | 30 | FINAL | 25 Jul, 2025 | Equity Share |
| 02 Aug, 2024 | 30 | FINAL | 02 Aug, 2024 | Equity Share |
| 11 Aug, 2023 | 30 | FINAL | 11 Aug, 2023 | Equity Share |
| 11 Aug, 2022 | 30 | FINAL | 12 Aug, 2022 | Equity Share |
| 17 Aug, 2021 | 20 | FINAL | Equity Share | |
| 25 Feb, 2020 | 16 | INTERIM | 26 Feb, 2020 | Equity Share |
| 14 Aug, 2019 | 16 | FINAL | Equity Share | |
| 31 Aug, 2018 | 10 | FINAL | Equity Share | |
| 15 Sep, 2017 | 10 | FINAL | Equity Share | |
| 17 Mar, 2016 | 10 | INTERIM | 18 Mar, 2016 | Equity Share |
Divi's Laboratories Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹770.85 | ₹1,138.40 | ₹1,811.40 | ₹1,705 | ₹2,409.60 | ₹178.59 |
| % Change | 0.72% | -3.19% | 0.25% | -1.92% | -1.95% | -0.48% |
| Revenue TTM (₹ Cr) | ₹2,124.33 | ₹2,192.49 | ₹1,421.59 | ₹9,203.54 | ₹14,277.64 | ₹8,869.07 |
| Net Profit TTM (₹ Cr) | ₹591.79 | ₹348.91 | ₹-73.80 | ₹924.36 | ₹1,912.93 | ₹-325.93 |
| PE TTM | 73.50 | 69.40 | -280.50 | 34.80 | 52.30 | -72.90 |
| 1 Year Return | 35.48 | 58.65 | 7.05 | 32.24 | -0.36 | -12.89 |
| ROCE | 27.56 | 18.38 | 0.59 | 25.65 | 14.32 | 2.29 |
Similar Stocks
ACUTAAS
Acutaas Chemicals Ltd.
₹ 3025.00
+3.46%
GLAND
Gland Pharma Ltd.
₹ 2302.40
-1.35%
LAURUSLABS
Laurus Labs Ltd.
₹ 1371.10
+1.09%
ALKEM
Alkem Laboratories Ltd.
₹ 5390.00
-0.19%
BIOCON
Biocon Ltd.
₹ 435.25
+1.21%
AJANTPHARM
Ajanta Pharma Ltd.
₹ 3098.50
+0.55%
ZYDUSLIFE
Zydus Lifesciences Ltd.
₹ 1077.00
+0.38%
GLENMARK
Glenmark Pharmaceuticals Ltd.
₹ 2359.00
+0.94%
WOCKPHARMA
Wockhardt Ltd.
₹ 1715.10
+4.73%
AUROPHARMA
Aurobindo Pharma Ltd.
₹ 1457.50
+0.20%
NATCOPHARM
Natco Pharma Ltd.
₹ 1190.00
+1.45%
SUNPHARMA
Sun Pharmaceutical Industries Ltd.
₹ 1842.50
+0.10%
NEULANDLAB
Neuland Laboratories Ltd.
₹ 17117.00
+2.14%
IPCALAB
Ipca Laboratories Ltd.
₹ 1579.80
+0.56%
JBCHEPHARM
J B Chemicals & Pharmaceuticals Ltd.
₹ 2191.50
-1.66%
ASTRAZEN
AstraZeneca Pharma India Ltd.
₹ 9025.00
+2.56%
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2282.00
-0.79%
PFIZER
Pfizer Ltd.
₹ 4636.90
-1.12%
ABBOTINDIA
Abbott India Ltd.
₹ 27605.00
-0.36%
TORNTPHARM
Torrent Pharmaceuticals Ltd.
₹ 4447.00
-2.75%
LUPIN
Lupin Ltd.
₹ 2256.00
-1.36%
DRREDDY
Dr. Reddy's Laboratories Ltd.
₹ 1329.60
-0.14%
CIPLA
Cipla Ltd.
₹ 1418.70
+0.34%
FAQ's on DIVISLAB
What is the current share price of Divi's Laboratories Ltd.?
What is the Market Capitalization of Divi's Laboratories Ltd.?
What are the PE and PB ratios for Divi's Laboratories Ltd.?
What is the 52-Week High and Low for Divi's Laboratories Ltd.?
What is the current dividend yield for Divi's Laboratories Ltd.?
Who are the major shareholders of Divi's Laboratories Ltd.?
- Promoter
- FII
- Mutual Funds
- Public
- Other Institutions
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
Who are the peers of Divi's Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?
What is the latest dividend information for Divi's Laboratories Ltd.?
By signing up I certify terms, conditions & privacy policy